Table 3.
Overall survival and risk of revision according to major explanatory factors
| Variable Category | S5 a | S10 a | RR | 95% CI | p-value |
|---|---|---|---|---|---|
| Gender | |||||
| Male | 90 | 85 | 1 | ||
| Female | 93 | 90 | 0.8 | 0.6–1.0 | 0.08 |
| Age, years | |||||
| 19–69 | 90 | 85 | 1 | ||
| ≥ 70 | 95 | 93 | 0.6 | 0.5–0.7 | < 0.001 |
| Diagnosis | |||||
| OA | 91 | 87 | 1 | ||
| RA | 92 | 88 | 0.9 | 0.7–1.3 | 0.6 |
| AF | 97 | 96 | 0.5 | 0.3–0.8 | 0.002 |
| FS | 88 | 85 | 1.5 | 1.1–2.1 | 0.008 |
| Prosthesis | |||||
| HP | 94 | 91 | 1 | ||
| ATP | 92 | 87 | 1.3 | 0.9–2.1 | 0.2 |
| RP | 88 | 83 | 1.7 | 1.2–2.4 | 0.001 |
| RTP | 92 | 85 | 1.7 | 1.3–2.3 | 0.001 |
| Time period | |||||
| 1994–1999 | 93 | 89 | 1 | ||
| 2000–2005 | 92 | 89 | 1.0 | 0.7–1.4 | 1.0 |
| 2006–2012 | 93 | - | 0.9 | 0.6–1.2 | 0.4 |
OA: osteoarthritis; RA: rheumatoid arthritis; AF: acute fracture; FS: fracture sequela; HP, ATP, RP, RTP: see Table 1.
aUnadjusted 5- and 10-year survival, in per cent.